Danielsson L, Furebring C, Ohlin M, Hultman L, Abrahamson M, Carlsson R, Borrebaeck C A
Department of Immunotechnology, Lund University, Sweden.
Immunology. 1991 Sep;74(1):50-4.
Human-mouse hybridoma cell lines producing human monoclonal antibodies against the cardiac glycoside digoxin were established after in vitro immunization or direct immortalization of human peripheral blood lymphocytes with digoxin. Three antibodies, designated MO6, LH92 and LH1114, displayed different patterns of fine specificity against digoxin and several digoxin analogues, as elucidated by inhibition ELISA. All three monoclonal antibodies had mu heavy chains, two of them (MO6 and LH114) had kappa light chains and one (LH92) lambda light chains. DNA encoding the variable regions of both heavy and light chains of the three antibodies were amplified from cDNA using the polymerase chain reaction (PCR). The nucleotide sequences of the amplified DNA were determined after subcloning of PCR fragments in M13 vectors. The deduced amino acid sequences revealed considerable sequence differences in the complementarity determining regions between the three antibodies.
在用洋地黄毒苷对人外周血淋巴细胞进行体外免疫或直接永生化后,建立了产生抗强心苷洋地黄毒苷的人单克隆抗体的人 - 鼠杂交瘤细胞系。通过抑制ELISA阐明,三种抗体,命名为MO6、LH92和LH1114,对洋地黄毒苷和几种洋地黄毒苷类似物表现出不同的精细特异性模式。所有三种单克隆抗体都有μ重链,其中两种(MO6和LH114)有κ轻链,一种(LH92)有λ轻链。使用聚合酶链反应(PCR)从cDNA中扩增出编码这三种抗体重链和轻链可变区的DNA。在将PCR片段亚克隆到M13载体中后,测定扩增DNA的核苷酸序列。推导的氨基酸序列显示这三种抗体的互补决定区之间存在相当大的序列差异。